ImpediMed Limited (IPDQF)
USD 0.03
(0.0%)
USD 0.03
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 10.05 Million | 11.34 Million | 10.49 Million | 8.35 Million | 5.69 Million | 4.09 Million |
| Cost of Revenue | 1.31 Million | 24.99 Million | 1.7 Million | 1.6 Million | 1.67 Million | 1.25 Million |
| Gross Profit | 8.73 Million | -13.65 Million | 8.78 Million | 6.75 Million | 4.01 Million | 2.84 Million |
| Operating Expenses | 9.99 Million | 9.19 Million | 30.32 Million | 29.82 Million | 29.57 Million | 29.85 Million |
| Selling, General and Administrative Expenses | 22.61 Million | 8.59 Million | 18.82 Million | 21.86 Million | 19.68 Million | 20.68 Million |
| Research and Development Expenses | 1.89 Million | 598 Thousand | 683 Thousand | 1.45 Million | 3.3 Million | 2.95 Million |
| Other Expenses | - | 1.7 Million | 1.69 Million | 2.43 Million | 4.18 Million | 2.69 Million |
| Cost and Expenses | 29.35 Million | 34.19 Million | 32.03 Million | 31.42 Million | 31.25 Million | 31.11 Million |
| Operating Income | -19.03 Million | -22.84 Million | -21.53 Million | -23.07 Million | -25.55 Million | -27.01 Million |
| Interest Expense | 93 Thousand | 34 Thousand | 28 Thousand | 52 Thousand | 73 Thousand | - |
| Income Tax Expense | 33 Thousand | -1.55 Million | 46 Thousand | 39 Thousand | 48 Thousand | 51 Thousand |
| Earnings before Tax | -19.75 Million | -22.07 Million | -19.82 Million | -20.66 Million | -21.32 Million | -23.94 Million |
| Net Income | -19.79 Million | -20.52 Million | -19.87 Million | -20.7 Million | -21.37 Million | -24.12 Million |
| Earnings Per Share Basic | -0.01 | -0.01 | -0.01 | -0.02 | -0.04 | -0.06 |
| Earnings Per Share Diluted | -0.01 | -0.01 | -0.01 | -0.02 | -0.04 | -0.06 |
| Weighted Average Shares Outstanding | 2.02 Billion | 1.8 Billion | 1.67 Billion | 1.2 Billion | 595.16 Million | 397.43 Million |
| Weighted Average Shares Outstanding (Diluted) | 2.02 Billion | 1.8 Billion | 1.67 Billion | 1.2 Billion | 595.16 Million | 397.43 Million |
| Gross Margin | 0.87 | -1.20 | 0.84 | 0.81 | 0.71 | 0.69 |
| EBIT Margin | -2.19 | -1.80 | -1.79 | -2.56 | -4.24 | -6.43 |
| Profit Margin | -1.97 | -1.81 | -1.89 | -2.48 | -3.75 | -5.89 |
| EBITDA | -22.05 Million | -20.49 Million | -18.76 Million | -21.37 Million | -24.12 Million | -26.33 Million |
| Earnings Before Tax Margin | -1.89 | -2.01 | -2.05 | -2.76 | -4.49 | -6.59 |
| Breakdown | 2024 Q4 | 2024 FY | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 |
|---|---|---|---|---|---|---|
| Revenue | 2.76 Million | 10.31 Million | 2.76 Million | 4.78 Million | 2.39 Million | 5.68 Million |
| Cost of Revenue | 341 Thousand | 24.29 Million | 341 Thousand | 12.61 Million | 316 Thousand | 12.1 Million |
| Gross Profit | 2.42 Million | -13.97 Million | 2.42 Million | -7.82 Million | 2.07 Million | -6.41 Million |
| Operating Expenses | -2.83 Million | 9.99 Million | -2.83 Million | 4.25 Million | 7.34 Million | 4.05 Million |
| Selling, General and Administrative Expenses | 5.86 Million | - | 5.86 Million | 4.13 Million | 7.2 Million | 3.94 Million |
| Research and Development Expenses | 883.5 Thousand | - | 883.5 Thousand | 125 Thousand | 62.5 Thousand | 111 Thousand |
| Other Expenses | -9.59 Million | 3.08 Million | -9.59 Million | - | - | - |
| Cost and Expenses | -2.49 Million | 34.29 Million | -2.49 Million | 16.86 Million | 7.65 Million | 16.16 Million |
| Operating Income | 5.26 Million | -23.97 Million | 5.26 Million | -12.08 Million | -6.45 Million | -10.47 Million |
| Interest Expense | 44 Thousand | 93 Thousand | - | 49 Thousand | - | 29 Thousand |
| Income Tax Expense | 6500.00 | -935 Thousand | 6500.00 | -518 Thousand | 10 Thousand | -496 Thousand |
| Earnings before Tax | -5.02 Million | -20.72 Million | -5.02 Million | -10.23 Million | -4.84 Million | -10.2 Million |
| Net Income | -5.03 Million | -19.79 Million | -5.03 Million | -9.71 Million | -4.85 Million | -9.7 Million |
| Earnings Per Share Basic | -0.00 | - | -0.00 | -0.00 | -0.00 | -0.01 |
| Earnings Per Share Diluted | -0.00 | - | -0.00 | -0.00 | -0.00 | -0.01 |
| Weighted Average Shares Outstanding | 2.04 Billion | 2.02 Billion | 2.04 Billion | 1.99 Billion | 1.99 Billion | 1.82 Billion |
| Weighted Average Shares Outstanding (Diluted) | 2.04 Billion | 2.02 Billion | 2.04 Billion | 1.99 Billion | 1.99 Billion | 1.82 Billion |
| Gross Margin | 0.88 | -1.35 | 0.88 | -1.64 | 0.87 | -1.13 |
| EBIT Margin | -1.96 | - | -1.90 | -2.28 | -2.46 | -1.61 |
| Profit Margin | -1.82 | -1.92 | -1.82 | -2.03 | -2.03 | -1.71 |
| EBITDA | -5.41 Million | - | -5.26 Million | -10.92 Million | -5.87 Million | -9.16 Million |
| Earnings Before Tax Margin | 1.90 | -2.32 | 1.90 | -2.53 | -2.70 | -1.84 |
4053
MLYCF
PYYX
GAV
CAZGF
KFY